Fintel reports that on March 7, 2025, Stifel downgraded their outlook for Neumora Therapeutics (NasdaqGS:NMRA) from Buy to Hold. Analyst Price Forecast Suggests 858.65% Upside As of March 4, 2025, the ...

Neumora Therapeutics (NASDAQ:NMRA) stock drops 11% as Stifel downgrades nothing that J&J (JNJ) discontinues a drug similar to NMRA's lead asset. Read more here.

In a report released today, Mark Astrachan from Stifel Nicolaus maintained a Buy rating on Costco (COST – Research Report), with a price target ...

Stifel downgraded Neumora Therapeutics (NMRA) to Hold from Buy with a price target of $2, down from $6. The shares are now “much harder to ...

Investment analysts at Stifel Nicolaus started coverage on shares of Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) in a ...

A Former Bradley basketball star was inducted into the Missouri Valley Conference Hall of Fame on Friday. Peoria Friendship ...

OrthoPediatrics (NASDAQ:KIDS – Get Free Report) had its price target cut by research analysts at Stifel Nicolaus from $40.00 to $32.00 in a report released on Wednesday,Benzinga reports. The firm ...

Find insight on Merck KGaA, Oceania Healthcare and more in the latest Market Talks covering the health care sector.

Inside the Explosive Meeting Where Trump Officials Clashed With Elon Musk Simmering anger at the billionaire’s unchecked power spilled out in a remarkable Cabinet Room meeting. The president ...

Daryl Hall has announced a new stretch of US tour dates going down in the summer of 2025 with Squeeze frontman Glen Tilbrook ...

The negative sentiment around volatile domestic stock markets is rippling out and has started hurting sales of consumer goods that recently showed some green shoots of recovery. Spotlight on India’s ...